{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:39:02Z","timestamp":1791283142025,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051698","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T20:33:10Z","timestamp":1355257990000},"page":"e51698","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography \u2013 A Cross Sectional Cohort Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Anne","family":"Langkilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Hedegaard","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Henrik","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"FJ Palella Jr","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995\u20132005","volume":"146","author":"N Lohse","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e32834dcec9","article-title":"Projected life expectancy of people with HIV according to timing of diagnosis","volume":"26","author":"F Nakagawa","year":"2012","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e22698","DOI":"10.1371\/journal.pone.0022698","article-title":"Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study","volume":"6","author":"N Obel","year":"2011","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Islam F, Wu J, Jansson J, Wilson D (2012) Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med.","DOI":"10.1111\/j.1468-1293.2012.00996.x"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Galli L, Salpietro S, Pellicciotta G, Galliani A, Piatti P, <etal>et al<\/etal>.. (2012) Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. Eur J Epidemiol.","DOI":"10.1007\/s10654-012-9707-5"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"MS Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"N Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lifson AR, Lando HA (2012) Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies. Curr HIV\/AIDS Rep.","DOI":"10.1007\/s11904-012-0121-0"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1360-0443.2009.02827.x","article-title":"Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study","volume":"105","author":"MV Larsen","year":"2010","journal-title":"Addiction"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"PC Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2337\/diabetes.54.10.2939","article-title":"Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation","volume":"54","author":"P Plomgaard","year":"2005","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e34218","DOI":"10.1371\/journal.pone.0034218","article-title":"Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study","volume":"7","author":"JK Lee","year":"2012","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"J Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/cir628","article-title":"Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses","volume":"53","author":"J Capeau","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"F Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref17","unstructured":"Ostrowski SR, Haastrup E, Langkilde A, Ullum H, Eugen-Olsen J (2009) The uPA\/uPAR system and suPAR in HIV infection. In: Massimo A, editor. Soluble factors mediating innate immune responses to HIV infection. Bentham E-Books. 85\u2013110."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1023099415940","article-title":"The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy","volume":"22","author":"N Sidenius","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"M Thuno","year":"2009","journal-title":"Dis Markers"},{"key":"ref20","first-page":"1","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission","volume":"0","author":"G Toldi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"O Andersen","year":"2008","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, <etal>et al<\/etal>.. (2010) Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med.","DOI":"10.1111\/j.1365-2796.2010.02252.x"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1373\/clinchem.2006.067595","article-title":"Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology","volume":"52","author":"K Kofoed","year":"2006","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","article-title":"Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection","volume":"96","author":"N Sidenius","year":"2000","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/1055-9965.EPI-10-1009","article-title":"Increased plasma soluble uPAR level is a risk marker of respiratory cancer in initially cancer-free individuals","volume":"20","author":"A Langkilde","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1468-1293.2009.00697.x","article-title":"The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy","volume":"10","author":"BR Hansen","year":"2009","journal-title":"HIV Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/JCD:8:3:287","article-title":"Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy","volume":"8","author":"E Bonnet","year":"2005","journal-title":"J Clin Densitom"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/aid.2006.22.715","article-title":"Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain","volume":"22","author":"MA Rodriguez-Arenas","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1086\/522557","article-title":"Optimizing treatment outcomes in HIV-infected patients with substance abuse issues","volume":"45","author":"DD Celentano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref31","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"E Wood","year":"2003","journal-title":"CMAJ"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Lyngbaek S, Sehestedt T, Marott JL, Hansen TW, Olsen MH, <etal>et al<\/etal>.. (2012) CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol.","DOI":"10.1016\/j.ijcard.2012.03.040"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00126334-200404010-00002","article-title":"Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients","volume":"35","author":"SR Ostrowski","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PSY.0b013e318177353e","article-title":"Behavioral mediation of the relationship between psychosocial factors and HIV disease progression","volume":"70","author":"C Gore-Felton","year":"2008","journal-title":"Psychosom Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-010-1149-y","article-title":"Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1","volume":"30","author":"ES Andersen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"G Greub","year":"2000","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jinf.2008.01.014","article-title":"suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART","volume":"57","author":"O Andersen","year":"2008","journal-title":"J Infect"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol.","DOI":"10.1038\/nrendo.2012.49"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, <etal>et al<\/etal>.. (2011) Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV Infection. AIDS.","DOI":"10.1097\/QAD.0b013e32834884e6"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"C Wei","year":"2011","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.qai.0000157950.02076.a6","article-title":"High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients","volume":"39","author":"SR Ostrowski","year":"2005","journal-title":"J Acquir Immune Defic Syndr"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0094152","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T13:40:01Z","timestamp":1595079601000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051698"}},"subtitle":[],"editor":[{"given":"Sunil K.","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051698","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0094152","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]}}}